Annual Drug Patent Expirations for RAVICTI
Ravicti is a drug marketed by Horizon Therap Us and is included in one NDA. It is available from one supplier. There are sixteen patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for RAVICTI.
This drug has ninety-three patent family members in twenty-nine countries.
The generic ingredient in RAVICTI is glycerol phenylbutyrate. One supplier is listed for this compound. Additional details are available on the glycerol phenylbutyrate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
